Abstract
IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Current Neuropharmacology
Title: Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists
Volume: 9 Issue: 1
Author(s): S. F. Ali, E. S. Onaivi, P. R. Dodd, J. L. Cadet, S. Schenk, M. J. Kuhar and G. F. Koob
Affiliation:
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Abstract: IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Export Options
About this article
Cite this article as:
F. Ali S., S. Onaivi E., R. Dodd P., L. Cadet J., Schenk S., J. Kuhar M. and F. Koob G., Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017245
DOI https://dx.doi.org/10.2174/157015911795017245 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Combination Therapeutic Approach for Asthma and Allergic Rhinitis
Current Clinical Pharmacology Delivery of Peptidic Gonadotropin Releasing Hormone Antagonists
Current Drug Delivery Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Targeted Temperature Management in Spontaneous Intracerebral Hemorrhage: A Systematic Review
Current Drug Targets Cytotoxicity and Anti-inflammatory Activity of Flavonoid Derivatives Targeting NF-kappaB
Recent Patents on Inflammation & Allergy Drug Discovery PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction
Current Hypertension Reviews Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Current Neuropharmacology Neuroprotective Effects of Medicinal Plants in Cerebral Hypoxia and Anoxia: A Systematic Review
The Natural Products Journal MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Necessity for Re-Vascularization after Spinal Cord Injury and the Search for Potential Therapeutic Options
Current Neurovascular Research The Oxido-reductase Activity of the Apoptosis Inducing Factor: A Promising Pharmacological Tool?
Current Pharmaceutical Design Review: Metabolism of Immunosuppressant Drugs
Current Drug Metabolism Thymulin: An Emerging Anti-Inflammatory Molecule
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents A Promising Future for Peptides in Ophthalmology: Work Effectively and Smartly
Current Medicinal Chemistry Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases
CNS & Neurological Disorders - Drug Targets Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery